Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Whirlpool Corporation (“Whirlpool” or the “Company”) (NYSE: WHR). Such investors are...
-
Útgerðarfélag Reykjavíkur hf. (ÚR) hélt lokað útboð á á nýjum 6 mánaða víxlaflokki UR 26 1201. ÚR hefur ákveðið að taka tilboðum að fjárhæð 1.440 m.kr. með 8,48% vöxtum, sem samsvarar 0,34% álagi á 6M...
-
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Angi Inc. (“Angi” or the “Company”) (NASDAQ: ANGI). Such investors are advised to contact...
-
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Forward Air Corporation (“Forward Air” or the “Company”) (NASDAQ: FWRD). Such investors...
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA). Such investors are advised to...
-
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of enGene Therapeutics Inc. (“Engene” or the “Company”) (NASDAQ: ENGN). Such investors are...
-
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG). Such investors are advised...
-
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA). Such investors are advised...
-
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Qiagen N.V. (“Qiagen” or the “Company”) (NYSE: QGEN). Such investors are advised to contact...
-
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bakkt, Inc. (“Bakkt” or the “Company”) (NYSE: BKKT). Such investors are advised to contact...